08.05.2014 Views

Introduction - Uppsala Monitoring Centre

Introduction - Uppsala Monitoring Centre

Introduction - Uppsala Monitoring Centre

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Douthwaite and Lintott first showed bleeding from the stomach via a gastroscope in<br />

1938. The semi-flexible gastroscope only having been invented in 1932 (Douthwaite<br />

and Lintott, 1938).<br />

The terminology in the 1900s was not as specific as that used in the present<br />

century, e.g. agranulocytosis was first described in 1922 as angina agranulocytotics<br />

(Hess et al., 1983), although aplastic anaemia was described as early as 1888 by<br />

Erlich (Erlich, 1888). Many of the early reports were couched in terms of symptoms<br />

such as dimness of vision, albuminuria and rashes, which were later, specified as<br />

individual specific disorders.<br />

In the various listings it is difficult to separate the ADRs occurring at normal<br />

therapeutic doses from those where an overdose has taken place due to large<br />

variations in individual responses.<br />

The sources for 2006 and 2007 (Meyler’s, Micromedex, Inchem and Martindale’s)<br />

do not mention peritoneal irritation, diarrhoea, vertigo, cardiac insufficiency,<br />

bradycardia, insomnia, agitation, dysarthria, polyuria, Cushing’s syndrome, haematuria,<br />

megaloblastic anaemia, alopecia or conjunctivitis. Although 11 of these were<br />

mentioned in earlier Meyler’s. In all I have traced 65 adverse events: Meyler’s; prior to<br />

2006; mentioned 56; Meyler’s 2006–40; Martindale 2007–28; Inchem 2007–40. There<br />

are probably several reasons why they have not included all of them: too rare, doubtful<br />

ADR or dealt with under a broader term.<br />

In planning any pharmacovigilance with a new drug one needs to examine the<br />

prior probabilities, which will be partly based on drugs of the same class, i.e. other<br />

salicylates. How soon were the predictable ADRs recognised with Aspirin?<br />

I contacted Bayer Archives with a view to obtaining more information about<br />

Aspirin ADRs, but I was unsuccessful.<br />

Relating serum salicylate concentration to symptoms<br />

For treatment of acute rheumatic fever the maintenance level should be 30–35<br />

mg. per 100cc. (Hoffman et al., 1949). The Mayo clinic considers the optimum<br />

level for rheumatoid arthritis to be 18–20 mg per 100cc., but may need from 60–<br />

125 grains (3.9 to 8.1 gm) a day (Greer et al., 1965). A single dose of Aspirin of<br />

2 gm. gave levels of 10 mg. per 100cc. A dose of 12 to 20 gr. (0.8 to 1.3 gm)<br />

every four hours until the desired level had been reached and then the same<br />

dose every six hours maintained levels of between 20 and 25 mg. per 100cc.<br />

(Hoffman et al., 1949). The toxic dose of sodium salicylate is between 12 and 30<br />

gr (0.78 gm to 1.95 gm) in a single dose (Duchesney, 1954).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!